impact factor, citescore
logo
 

LER & CER: letter to Editor Rheumatology

 

Reply to: Behçet’s disease: an MHC-I-opathy?


1, 2, 3, 4, 5

 

  1. Section of Musculoskeletal Diseases, The Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and Chapel Allerton Hospital, Leeds, UK.
  2. Rheumatology Division, University of Ottawa, Canada. drsibelaydin@gmail.com
  3. Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Turkey.
  4. Department of Internal Medicine, Hospital Saint-Louis, University Paris 7 – Diderot, Paris, France.
  5. Department of Internal Medicine, Division of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey.

CER9628
2017 Vol.35, N°2 ,Suppl.104
PI 0006
LER & CER: letter to Editor Rheumatology

Free to view
(click on article PDF icon to read the article)

PMID: 28421994 [PubMed]

Received: 01/06/2016
Accepted : 01/06/2016
In Press: 14/04/2017
Published: 29/05/2017

Rheumatology Article